ventricular ectopy. In contrast, brain injury is managed with neurostimulants which promote cholinergic activity. Moreover, there is no FDA approved neurostimulant dose that can be administered to patients under six years old. To our knowledge, this is the first reported case of neurostimulant use in a patient under six years old with hereditary ventricular tachycardia and anoxic brain injury. Conclusions: Neurostimulant use for treatment of brain injury in children with ventricular arrhythmia is possible despite the cholinergic side effects and no approved pediatric dosing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.